期刊文献+

泄浊解毒方对溃疡性结肠炎大鼠TNF-α、NF-κB、ICAM-1的影响

THE EFFECTS OF XIEZHUOJIEDU DECOCTION ON THE EXPRESSION OF TNF-α,NF-κB,ICAM -1 IN ULCERATIVE COLITIS RATS
下载PDF
导出
摘要 目的观察泄浊解毒方对溃疡性结肠炎大鼠肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、核因子-κB(nuclear factor-kappa B,NF-κB)、黏附分子-1(tntercellular adhesion molecule-1,ICAM-1)的影响并探讨其作用机制。方法 2,4,6-三硝基苯磺酸/乙醇混合溶液灌肠复制溃疡性结肠炎大鼠模型。实验设正常组、模型组、柳氮磺胺吡啶组、中药泄浊解毒方小、大剂量组;观察大鼠结肠病理形态学改变(疾病活动指数评分及黏膜损伤指数评分),采用放射免疫法测定TNF-α,运用免疫组织化学染色(SP法)检测NF-κB、ICAM-1表达。结果泄浊解毒方可明显降低大鼠结肠黏膜损伤指数评分,减少NF-κB、ICAM-1表达,降低TNF-α的含量。结论泄浊解毒方对大鼠溃疡性结肠炎有良好的治疗作用,其作用机制可能与减少NF-κB、ICAM-1表达,降低TNF-α的含量有关。 Objective To observe the effects of Xiezhuojiedu decoction on the expression of tumor necrosis factor - st ( TNF - st ), nuclear factor - kappa B ( NF - KB ), tntercellular adhesion molecule- 1 (ICAM -1 ) in ulcerative colitis rats, and study its mechanism. Methods 2,4,6 - trinitrobenzene sulfonic acid/ethanol solution was administrated by enema to make ulcerative colitis rats models. Five groups were set up in the experiment including normal control group, model control group, salazosulfamide group, Xiezhuojiedu decoction low -dose group, Xiezhuojiedu decoction high -dose group;The pathomorphological observation was carried out on the rats'colon disease activity index (DAI) scores and colon mucosal damage index (CMDI). TNF - st was determined by radioimmunoassay ; The expression of NF - KB and ICAM - 1 was determined by immunohistochemical staining. Results Xiezhuojiedu decoction can significantly decrease the CMDI scores, decrease the content of TNF- st, reduce the expression of NF - KB and ICAM - 1. Conclusion Xiezhuojiedu decoction has good therapeutic effect on ulcerative colitis in rats , its mechanism may be related to decreasing the content of TNF - st, and reducing the expression of NF - KB and ICAM - 1.
出处 《河北医科大学学报》 CAS 2011年第4期373-376,共4页 Journal of Hebei Medical University
基金 国家中医药管理局浊毒实验室资助项目(ZD200812-12) 河北省科技厅资助项目(09276102D-39)
关键词 结肠炎 肿瘤坏死因子-Α NF-ΚB colitis tumor necrosis factor - alpha NF - kappa B
  • 相关文献

参考文献8

二级参考文献37

  • 1宫健伟,苑述刚,阮时宝.对免疫方法制作溃疡性结肠炎动物模型的探讨[J].中国实验方剂学杂志,2005,11(2):70-71. 被引量:41
  • 2中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119. 被引量:985
  • 3Ross R. Atherosclerosis - AN inflammatory disease N Engl Med 1999; 340: 115-126 被引量:1
  • 4Meyer-Siegler KL, Leifheit EC, Vera PL. Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 2004; 4: 34 被引量:1
  • 5Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002; 4: 449-460 被引量:1
  • 6de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Alsahli M, ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Michetti P, van Deventer SJ, Lolis E, David JR, Bhan AK, Terhorst C.Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2: 1061-1066 被引量:1
  • 7Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T, Iwanaga T, Nakamura H, Mizue Y, Asaka M. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.Gastroenterology 2002; 123: 256-270 被引量:1
  • 8Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance.Eur J Clin Invest 2001; 31: 337-343 被引量:1
  • 9Murano M, Maemura K, Hirata I, Toshina K, Nishikawa T, Hamamoto N, Sasaki S, Saitoh O, Katsu K. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol 2000; 120: 51-58 被引量:1
  • 10Targan SR, Karp LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 2005; 206: 296-305 被引量:1

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部